Literature DB >> 16330894

Blood pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine.

Juan Carlos Yugar-Toledo1, Silvia Elaine Ferreira-Melo, Maricene Sabha, Eduardo Arantes Nogueira, Otávio Rizzi Coelho, Fernanda Marciano Consolin Colombo, Maria Cláudia Irigoyen, Heitor Moreno.   

Abstract

Nicotine replacement therapy appears to be safe when used by healthy patients to aid in smoking cessation; however, the immediate acute effects of nicotine replacement therapy on the circadian rhythm of blood pressure (BP) and endothelial function in heavy smokers are not well understood. Twenty-six heavy smokers were requested to stop smoking for 48 hours. BP and heart rate were recorded over 48 hours by ambulatory BP monitoring, with beat-to-beat changes being monitored for the first 10 hours by a noninvasive finger device. The reactivity of the brachial artery was evaluated using flow-mediated dilation immediately after smoking cessation, before the application of a 21-mg nicotine patch or placebo patch, and 24 hours after patch placement. Transdermal nicotine caused a mild but significant elevation in BP in the early morning in 21 of 26 volunteers. The decrease in nocturnal BP was attenuated in patients with the nicotine patch compared with the placebo patch; this was associated with impaired endothelium-dependent vasodilation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330894      PMCID: PMC8109293          DOI: 10.1111/j.1524-6175.2005.04597.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  50 in total

1.  Influence of smoking on baroreceptor function: 24 h measurements.

Authors:  U Gerhardt; U Hans; H Hohage
Journal:  J Hypertens       Date:  1999-07       Impact factor: 4.844

2.  Dose-related cardiovascular and endocrine effects of transdermal nicotine.

Authors:  S Zevin; P Jacob; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  1998-07       Impact factor: 6.875

Review 3.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.

Authors:  N L Benowitz
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

4.  Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing.

Authors:  G Parati; R Casadei; A Groppelli; M Di Rienzo; G Mancia
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

5.  Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study.

Authors:  D R Jacobs; H Adachi; I Mulder; D Kromhout; A Menotti; A Nissinen; H Blackburn
Journal:  Arch Intern Med       Date:  1999-04-12

6.  Transdermal nicotine mimics the smoking-induced endothelial dysfunction.

Authors:  M Sabha; J E Tanus-Santos; J C Toledo; M Cittadino; J C Rocha; H Moreno
Journal:  Clin Pharmacol Ther       Date:  2000-08       Impact factor: 6.875

Review 7.  Cigarette smoking, endothelial injury and cardiovascular disease.

Authors:  R Michael Pittilo
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

8.  Modulation of nitric-oxide synthase by nicotine.

Authors:  B H Tonnessen; S R Severson; R D Hurt; V M Miller
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

9.  Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.

Authors:  J A Panza; P R Casino; C M Kilcoyne; A A Quyyumi
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

10.  Effect of nicotine infusion in humans on platelet aggregation and urinary excretion of a major thromboxane metabolite.

Authors:  J Nowak; K Andersson; G Benthin; J Chen; K E Karlberg; C Sylvén
Journal:  Acta Physiol Scand       Date:  1996-05
View more
  10 in total

1.  Greater γ-tocopherol status during acute smoking abstinence with nicotine replacement therapy improved vascular endothelial function by decreasing 8-iso-15(S)-prostaglandin F2α.

Authors:  Eunice Mah; Ruisong Pei; Yi Guo; Christopher Masterjohn; Kevin D Ballard; Beth A Taylor; Alan W Taylor; Maret G Traber; Jeff S Volek; Richard S Bruno
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-30

2.  The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.

Authors:  John D Beaver; Christopher J Long; David M Cole; Michael J Durcan; Linda C Bannon; Rajesh G Mishra; Paul M Matthews
Journal:  Neuropsychopharmacology       Date:  2011-05-04       Impact factor: 7.853

3.  Effects of nicotine on cardiovascular remodeling in a mouse model of systemic hypertension.

Authors:  E Sage Colombo; Joshua Davis; Mehran Makvandi; Mario Aragon; Selita N Lucas; Michael L Paffett; Matthew J Campen
Journal:  Cardiovasc Toxicol       Date:  2013-12       Impact factor: 3.231

4.  Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study.

Authors:  Britta Hahn; Thomas J Ross; Frank A Wolkenberg; Diaa M Shakleya; Marilyn A Huestis; Elliot A Stein
Journal:  Cereb Cortex       Date:  2008-12-10       Impact factor: 5.357

5.  Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network.

Authors:  Britta Hahn; Thomas J Ross; Yihong Yang; Insook Kim; Marilyn A Huestis; Elliot A Stein
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

Review 6.  Cardiovascular effects of pharmacologic therapies for smoking cessation.

Authors:  Diana M Sobieraj; William B White; William L Baker
Journal:  J Am Soc Hypertens       Date:  2012-12-21

7.  The impact of tetrahydrobiopterin administration on endothelial function before and after smoking cessation in chronic smokers.

Authors:  Beth A Taylor; Amanda L Zaleski; Ellen A Dornelas; Paul D Thompson
Journal:  Hypertens Res       Date:  2015-11-26       Impact factor: 3.872

8.  Lifestyle change important for patients with hypertension and cardiovascular diseases.

Authors:  Murat Karaman; Sevket Balta; Mustafa Cakar; Seyid A Ay; Mustafa Dinc
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-01       Impact factor: 3.738

9.  Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.

Authors:  André Pacheco Silva; Jaqueline Scholz; Tania Ogawa Abe; Gabriela Gouveia Pinheiro; Patricia Viviane Gaya; Alexandre Costa Pereira; Paulo Caleb Junior Lima Santos
Journal:  BMC Cardiovasc Disord       Date:  2016-01-05       Impact factor: 2.298

10.  Dialysis patients who smoke are more hypertensive, more fluid overloaded and take more antihypertensive medications than nonsmokers.

Authors:  Mihály Tapolyai; Melinda Forró; Zsolt Lengvárszky; Tibor Fülöp
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.